Triple-negative breast cancer (TNBC), which represents 10–20% of all breast cancers, is characterized by a lack of expression of the estrogen steroid receptor (ER), progesterone steroid receptor (PR), and tyrosine kinase human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ERBB2 and breast carcinoma.